|
2023-02-27 |
2022-11-28 |
V
Vente
|
Administrateur non-exécutif
Actionnaire important
|
87 041
+12.5%
108,87
3 861 741 $US
|
87 041
+12.5%
|
108,87
|
3 861 741 $US
|
|
|
2022-08-17 |
2022-08-15 |
A
Achat
|
Actionnaire important
|
90 660
+27.6%
116,04
1 393 225 $US
|
90 660
+27.6%
|
116,04
|
1 393 225 $US
|
|
|
2022-08-17 |
2022-08-15 |
A
Achat
|
Actionnaire important
|
29 604
+3.0%
45,23
1 121 201 $US
|
29 604
+3.0%
|
45,23
|
1 121 201 $US
|
|
|
2022-08-17 |
2022-08-15 |
A
Achat
|
Actionnaire important
|
133 333
+3.3%
30,00
3 999 990 $US
|
133 333
+3.3%
|
30,00
|
3 999 990 $US
|
|
|
2022-08-15 |
2022-08-11 |
A
Achat
|
Actionnaire important
|
83 000
+2.0%
30,00
2 490 000 $US
|
83 000
+2.0%
|
30,00
|
2 490 000 $US
|
|
|
2022-08-15 |
2022-08-11 |
A
Achat
|
Actionnaire important
|
500 000
+9.0%
30,00
15 000 000 $US
|
500 000
+9.0%
|
30,00
|
15 000 000 $US
|
|
|
2022-08-15 |
2022-08-11 |
A
Achat
|
Actionnaire important
|
83 000
+2.0%
30,00
2 490 000 $US
|
83 000
+2.0%
|
30,00
|
2 490 000 $US
|
|
|
2022-08-15 |
2022-08-11 |
A
Achat
|
Administrateur non-exécutif
Actionnaire important
|
6 000
+inf%
30,00
180 000 $US
|
6 000
+inf%
|
30,00
|
180 000 $US
|
|
|
2022-08-15 |
2022-08-11 |
A
Achat
|
Administrateur non-exécutif
Actionnaire important
|
500 000
+9.0%
30,00
15 000 000 $US
|
500 000
+9.0%
|
30,00
|
15 000 000 $US
|
|
|
2023-02-27 |
2022-06-10 |
V
Vente
|
Chief Medical Officer
Dirigeant
|
6
-0.2%
15,21
91 $US
|
6
-0.2%
|
15,21
|
91 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
EVP CFO & Chief BD Officer
Dirigeant
|
100
+inf%
16,00
1 600 $US
|
100
+inf%
|
16,00
|
1 600 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Actionnaire important
|
325 000
+6.2%
16,00
5 200 000 $US
|
325 000
+6.2%
|
16,00
|
5 200 000 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Administrateur non-exécutif
Actionnaire important
|
325 000
+6.2%
16,00
5 200 000 $US
|
325 000
+6.2%
|
16,00
|
5 200 000 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Actionnaire important
|
220 000
+5.7%
16,00
3 520 000 $US
|
220 000
+5.7%
|
16,00
|
3 520 000 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Actionnaire important
|
312 500
+170.0%
16,00
5 000 000 $US
|
312 500
+170.0%
|
16,00
|
5 000 000 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Actionnaire important
|
157 500
+4.3%
16,00
2 520 000 $US
|
157 500
+4.3%
|
16,00
|
2 520 000 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Actionnaire important
|
1 700 000
+70.1%
16,00
27 200 000 $US
|
1 700 000
+70.1%
|
16,00
|
27 200 000 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Chief Executive Officer
Administrateur exécutif
|
12 500
+inf%
16,00
200 000 $US
|
12 500
+inf%
|
16,00
|
200 000 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Chief Operating Officer
Dirigeant
|
1 500
+inf%
16,00
24 000 $US
|
1 500
+inf%
|
16,00
|
24 000 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Chief Operating Officer
Dirigeant
|
750
+0.6%
16,00
12 000 $US
|
750
+0.6%
|
16,00
|
12 000 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
EVP Clinical Development
Dirigeant
|
100
+inf%
16,00
1 600 $US
|
100
+inf%
|
16,00
|
1 600 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
EVP Clinical Development
Dirigeant
|
2 500
+inf%
16,00
40 000 $US
|
2 500
+inf%
|
16,00
|
40 000 $US
|
|
|
2022-01-13 |
2022-01-11 |
A
Achat
|
Actionnaire important
|
1 700 000
+70.1%
16,00
27 200 000 $US
|
1 700 000
+70.1%
|
16,00
|
27 200 000 $US
|
|